Community-Acquired Pneumonia (CAP) Surveillance

Completed

• Conditions: Pneumonia
• Interventions: Other: No Drug

• Registration Number: NCT01416506
• Lead Sponsor: Bayer

Brief Summary

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09
• Study First Submitted: 2011-08-12
• Study First Submitted QC: 2011-08-12
• Study First Posted: 2011-08-15
• Primary Completion: 2012-08
• Study Completion: 2013-01
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-04
• Last Update Posted: 2013-11-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 560

Inclusion Criteria

• Chinese adult (male or female) ≥18 years old
• Outpatients or inpatients who suffer from CAP

Read More

Exclusion Criteria

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Group 1	No Drug	-

Primary Outcome Measures

Name	Time	Method
In vitro Minimal Inhibitory Concentration Detection	Up to 27 months

Secondary Outcome Measures

Name	Time	Method
In vitro Gene Mutation Detection	Up to 15 months